SIGA vs RIGL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RIGL Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Rigel Pharmaceuticals Inc. (New) (RIGL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SIGA counters with relative strength in Valuation. Fundamentally, SIGA trades at 2.5x Forward P/E with -14.2% operating margin (-49.7% YoY revenue) versus RIGL at 8.6x Forward P/E and 26.3% operating margin (+16.5% YoY). In options structure, SIGA sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro) against RIGL sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SIGA Revenue | RIGL Revenue | SIGA Op. Margin | RIGL Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $480M | $40M | 74.4% | -163.3% | SIGA |
| FY2019 | $30M | $60M | -8.7% | -116.5% | SIGA |
| FY2020 | $120M | $110M | 67.6% | -26.7% | SIGA |
| FY2021 | $130M | $150M | 66.7% | -8.4% | SIGA |
| FY2022 | $110M | $120M | 38.5% | -46.2% | SIGA |
| FY2023 | $140M | $120M | 59.8% | -17.5% | SIGA |
| FY2024 | $140M | $180M | 50.4% | 13.5% | SIGA |
| FY2025 | $90M | $290M | 25.1% | 42.6% | RIGL |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SIGA | RIGL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $187.9M | $800.8M | Larger Scale | RIGL |
| Trailing P/E Ratio Valuation | N/M | 2.6x | Lower Multiple | RIGL |
| Forward P/E Ratio Valuation | 2.5x | 8.6x | Lower Multiple | SIGA |
| Revenue Growth (YoY) Growth | -49.7% | +16.5% | Higher Growth | RIGL |
| Operating Margin (TTM) Profitability | -14.2% | 26.3% | Higher Margin | RIGL |
| Net Profit Margin Profitability | 1.3% | 106.6% | Higher Margin | RIGL |
| Return on Equity (ROE) Capital Efficiency | 0.4% | 109.2% | Higher ROE | RIGL |
| 52-Week Range Position Momentum | 3% ($3โ$7) | 59% ($25โ$53) | Stronger Trend | RIGL |
| Beta / 30D Volatility Risk Regime | 0.75ฮฒ ยท 65% Vol | 1.06ฮฒ ยท 72% Vol | Lower Realized Risk | SIGA |
| Unified Institutional Score Composite Signal | 47.5 / 100 (HOLD) | 61.3 / 100 (BUY) | Higher Composite | RIGL |